Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Observational, and Multicenter Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19

NCT07269587 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07269587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07269587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Observational, and Multicenter Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
November 7, 2025
Completion date
November 30, 2027
Enrollment
275 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

all (acute b-lymphoblastic leukemia), car-t cell therapy